Innovative drug approvals
Total number of innovative pharmaceutical products granted regulatory marketing authorization.
Unit Count Industry Pharmaceuticals
The chart
Over time
China over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Innovative drug approvals
China, 2024 to 2025
Every record
All records
5 records · 1 region · 2024–2025
Primary documents
Sources
3 documents. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 2025年我国批准创新药76个 对外授权超千亿美元 | MOFCOM | — | 2 |
| 国家医疗保障局 医保动态 创新高！去年我国批准创新药76个 对外授权破千亿美元 | NHSA | — | 2 |
| 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网 | State Council | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Innovative drug approvals. Retrieved from https://statorigin.org/indicators/innovative-drug-approvals